Quite apart from its role in normal biology (including development) the ERK1/2 pathway is strongly implicated in cancer 10, 11 and our appreciation of its role in cell death/survival signalling has emerged, in part, from studies in cancer cells where the pathway is deregulated. Here, MAPK3 is linked to cancer.